← Back to Clinical Trials
Recruiting NCT06723327

NCT06723327 The Effect of Preoperative Culture Timing on Postoperative Outcomes of Retrograde Intrarenal Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06723327
Status Recruiting
Phase
Sponsor Namik Kemal University
Condition Urinary Infections
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2024-12-01
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2024-12-01 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The rate of complications (unexpected situations) after retrograde intrarenal surgery is reported to be 9-25%, and the majority of these are postoperative infections. Surgery must be performed under sterile (microbial-free) urine culture to prevent these complications. There are guideline recommendations regarding sterile urine culture reporting, but it is not clear how long in advance it should be taken. The possibility of the patient becoming infectious again during the period leading up to surgery is a condition that needs to be determined. Therefore, the culture taken before surgery should be compared with the urine culture result taken at the latest possible time before the operation.

Eligibility Criteria

Inclusion Criteria: * Patients over 18 years of age * Patients who had a urine culture taken 2 weeks before the operation and reported as sterile Exclusion Criteria: * Patients under 18 years of age * Patients without sufficient data * Patients with a urine culture more than 2 weeks before retrograde intrarenal -surgery * Patients with a positive urine culture before retrograde intrarenal surgery * Patients with renal anatomic anomalies * Patients with a solitary (single) kidney

Contact & Investigator

Central Contact

Mehmet F. Şahin, Assistant Professor

✉ mfatihsahin@gmail.com

📞 05555511871

Frequently Asked Questions

Who can join the NCT06723327 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Urinary Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06723327 currently recruiting?

Yes, NCT06723327 is actively recruiting participants. Contact the research team at mfatihsahin@gmail.com for enrollment information.

Where is the NCT06723327 trial being conducted?

This trial is being conducted at Tekirdağ, Turkey (Türkiye).

Who is sponsoring the NCT06723327 clinical trial?

NCT06723327 is sponsored by Namik Kemal University. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology